Published on October 12, 2018
FRIDAY, October 5, 2018 (The Washington Post) The Food and Drug Administration expanded its approval of the HPV vaccine to include men and women between 27 and 45, an effort to protect more people from several types of cancer caused by the human papillomavirus.
The vaccine, called Gardasil 9, previously was approved for people ages 9 through 26. The vaccine is typically given in two doses several months apart for those who are 9 through 14, and in three doses for individuals 15 through 26. For those older than 26, the recommended regimen will be three doses.
We cannot let e-cigarettes become an on-ramp for teenage addiction
Oct. 11, The Washington Post
Lyft and Uber Help Patients Make It to Medical Appointments
Oct. 10, U.S. News & World Report